{
    "abstract": "Anti-Jo-1 antisynthetase syndrome (Jo1\nA single-center retrospective cohort of patients with Jo1\nA total of 166 eligible treatment regimens, including CD20mAbs and csDMARDs, were extracted from 128 Jo1\nCD20mAbs exhibited remarkable treatment efficacy and acceptable safety in patients with Jo1",
    "authors": [
        {
            "affiliation": "Department of Rheumatology, South Campus, RenJi Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.",
            "firstname": "Shuhui",
            "initials": "S",
            "lastname": "Sun"
        },
        {
            "affiliation": "Department of Rheumatology, South Campus, RenJi Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.",
            "firstname": "Jiajia",
            "initials": "J",
            "lastname": "Jin"
        },
        {
            "affiliation": "Department of Rheumatology, South Campus, RenJi Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.",
            "firstname": "Jie",
            "initials": "J",
            "lastname": "Chen"
        },
        {
            "affiliation": "Department of Rheumatology, South Campus, RenJi Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.",
            "firstname": "Kaiwen",
            "initials": "K",
            "lastname": "Wang"
        },
        {
            "affiliation": "Department of Rheumatology, South Campus, RenJi Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.",
            "firstname": "Wanlong",
            "initials": "W",
            "lastname": "Wu"
        },
        {
            "affiliation": "Department of Rheumatology, South Campus, RenJi Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.",
            "firstname": "Xiaodong",
            "initials": "X",
            "lastname": "Wang"
        },
        {
            "affiliation": "Department of Biostatistics, Clinical Research Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China.",
            "firstname": "Yanyan",
            "initials": "Y",
            "lastname": "Song"
        },
        {
            "affiliation": "Department of Rheumatology, South Campus, RenJi Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: ye_shuang2000@163.com.",
            "firstname": "Shuang",
            "initials": "S",
            "lastname": "Ye"
        }
    ],
    "conclusions": "CD20mAbs exhibited remarkable treatment efficacy and acceptable safety in patients with Jo1",
    "copyrights": "Copyright \u00a9 2025. Published by Elsevier Inc.",
    "doi": "10.1016/j.semarthrit.2025.152712",
    "journal": "Seminars in arthritis and rheumatism",
    "keywords": [
        "Anti-Jo-1 antibody",
        "Anti-synthetase syndrome",
        "CD20mAbs",
        "csDMARDs"
    ],
    "methods": null,
    "publication_date": "2025-03-24",
    "pubmed_id": "40122014",
    "results": "A total of 166 eligible treatment regimens, including CD20mAbs and csDMARDs, were extracted from 128 Jo1",
    "title": "Effectiveness and safety of anti-CD20 monoclonal antibodies versus csDMARDs in anti-Jo-1 antisynthetase syndrome: A retrospective cohort study.",
    "xml": "<Element 'PubmedArticle' at 0x788504bd95d0>"
}